ZA201406901B - Combination treatment comprising sulphated glycosaminoglycans for inducing labor - Google Patents

Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Info

Publication number
ZA201406901B
ZA201406901B ZA2014/06901A ZA201406901A ZA201406901B ZA 201406901 B ZA201406901 B ZA 201406901B ZA 2014/06901 A ZA2014/06901 A ZA 2014/06901A ZA 201406901 A ZA201406901 A ZA 201406901A ZA 201406901 B ZA201406901 B ZA 201406901B
Authority
ZA
South Africa
Prior art keywords
combination treatment
inducing labor
sulphated glycosaminoglycans
sulphated
glycosaminoglycans
Prior art date
Application number
ZA2014/06901A
Other languages
English (en)
Inventor
Anders Malmström Malmström
Gunvor Ekman-Ordeberg
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of ZA201406901B publication Critical patent/ZA201406901B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2014/06901A 2012-03-26 2014-09-16 Combination treatment comprising sulphated glycosaminoglycans for inducing labor ZA201406901B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615398P 2012-03-26 2012-03-26
PCT/SE2013/050332 WO2013147689A1 (en) 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Publications (1)

Publication Number Publication Date
ZA201406901B true ZA201406901B (en) 2017-09-27

Family

ID=49260783

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/06901A ZA201406901B (en) 2012-03-26 2014-09-16 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Country Status (15)

Country Link
US (1) US20150045322A1 (enExample)
EP (1) EP2830635A4 (enExample)
JP (1) JP6234989B2 (enExample)
CN (1) CN104203256B (enExample)
AU (1) AU2013240597A1 (enExample)
CA (1) CA2868444A1 (enExample)
HK (1) HK1203369A1 (enExample)
IL (1) IL234689A0 (enExample)
MX (1) MX2014011505A (enExample)
MY (1) MY175743A (enExample)
RU (1) RU2014143017A (enExample)
SG (1) SG11201406119WA (enExample)
UA (1) UA117908C2 (enExample)
WO (1) WO2013147689A1 (enExample)
ZA (1) ZA201406901B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
SMT201800143T1 (it) 2011-12-19 2018-05-02 Dilafor Ab Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico
CA2868403A1 (en) * 2012-05-08 2013-11-14 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
KR20220142508A (ko) * 2020-02-17 2022-10-21 딜라포 아베 자간전증 치료용 타폭시파린
CA3255831A1 (en) 2022-05-03 2023-11-09 Dilafor Ab NEW MEDICAL USE OF TAFOXIPARIN
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5993810A (en) * 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
KR20140097380A (ko) * 2011-11-28 2014-08-06 코닝 인코포레이티드 평면 투명 시트를 사용한,강력한 광학 터치 스크린 시스템 및 방법
SMT201800143T1 (it) * 2011-12-19 2018-05-02 Dilafor Ab Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico

Also Published As

Publication number Publication date
WO2013147689A1 (en) 2013-10-03
US20150045322A1 (en) 2015-02-12
SG11201406119WA (en) 2014-11-27
MY175743A (en) 2020-07-07
AU2013240597A1 (en) 2014-10-16
IL234689A0 (en) 2014-11-30
HK1203369A1 (en) 2015-10-30
CA2868444A1 (en) 2013-10-03
JP6234989B2 (ja) 2017-11-22
CN104203256B (zh) 2017-11-24
EP2830635A4 (en) 2016-03-16
UA117908C2 (uk) 2018-10-25
JP2015511664A (ja) 2015-04-20
EP2830635A1 (en) 2015-02-04
MX2014011505A (es) 2014-12-05
CN104203256A (zh) 2014-12-10
RU2014143017A (ru) 2016-05-20

Similar Documents

Publication Publication Date Title
EP2787497A4 (en) DEFAULT ASSESSMENT APPARATUS
EP2815691A4 (en) ENDOSCOPE
EP2692278A4 (en) Borescope
EP2820999A4 (en) ENDOSCOPE
EP2891448A4 (en) ENDOSCOPE
EP2837320A4 (en) Borescope
EP2835093A4 (en) ENDOSCOPE
EP2868252A4 (en) Borescope
GB201218575D0 (en) Nephroureterectomy apparatus
EP2856924A4 (en) Borescope
EP2865318A4 (en) ENDOSCOPE
GB201212900D0 (en) Triage scoring system
ZA201406901B (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
ZA201501562B (en) Treatment regimens
EP2889035A4 (en) ANTI-TUMOR AGENT
GB201215796D0 (en) Apparatus
GB201204981D0 (en) Pre-harvest treatment
IL217807A0 (en) Therapeutic compositions
EP2822545A4 (en) TREATMENT OF HIGH RATE OF CHOLESTEROL
GB201201805D0 (en) Speculum
GB2503675B (en) Brackets
GB2498997B (en) Oven cleaning system
GB201211135D0 (en) Treatment
GB201208690D0 (en) Treatment
GB201212604D0 (en) New treatment